Bacterial expression and characterization of an anti-CD22 single-chain antibody fragment
Authors:
- Diana MikiewiczDMDiana Mikiewicz
- Natalia ŁukasiewiczNŁNatalia Łukasiewicz
- Marcin ZielińskiMZMarcin Zieliński
- Violetta Cecuda-AdamczewskaVCVioletta Cecuda-Adamczewska
- Anna Bierczyńska-KrzysikABAnna Bierczyńska-Krzysik
- Agnieszka Romanik-ChruścielewskaARAgnieszka Romanik-Chruścielewska
- Małgorzata Kęsik-BrodackaMKMałgorzata Kęsik-Brodacka
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Protein Expression and Purification
- Vol. 170, 105594
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemiaBlood, 2013
- Antibody Fusion Proteins: Anti-CD22 Recombinant Immunotoxin Moxetumomab PasudotoxClinical Cancer Research, 2011
- Cell culture processes for monoclonal antibody productionmAbs, 2010
- Applications of single-chain variable fragment antibodies in therapeutics and diagnosticsBiotechnology Advances, 2009
- CAT-8015: A Second-GenerationPseudomonasExotoxin A–Based Immunotherapy Targeting CD22-Expressing Hematologic MalignanciesClinical Cancer Research, 2009
- CD22: an inhibitory enigmaImmunology, 2008
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coliProtein Expression and Purification, 2005
- Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21–47) fragment of HBsAgProtein Expression and Purification, 2005
- CD22 as a target of passive immunotherapySeminars in Oncology, 2003